Active Ingredient History

  • Now
Radium Ra 223 dichloride is a radiotherapeutic drug that is approved for the treatment of male patients with symptoms of advanced prostate cancer with bone metastases. Ra 223 mimics calcium and forms complexes with the bone mineral hydroxyapatite at areas of increased bone turnover. The radioactive alpha particles emitted by radium Ra 223 helps in killing cancer cells in the bone by damaging their DNA. Radium Ra 223 causes minimal damage to the nearby healthy cells.   NCATS

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$16.9250 - $22.4367
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

alpharadin | bay 88-8223 | ra223 | ra 223 dichloride | radium-223 | radium-223 chloride | radium-223 dichloride | radium (223ra) dichloride | radium chloride ra 223 | radium chloride ra-223 | radium dichloride | radium ra-223 | radium ra 223 dichloride | radium ra-223 dichloride | radium ra223 dichloride | xofigo


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue